ARCHIVES

Trial In Metastatic Disease To Be Unblinded After Regorafenib Meets Primary Endpoint

This article is from The Cancer Letter archive.

Vol. 34 No. 11 | November 25, 2011

Download PDF Visit The Full Archive

Related Articles

In Brief: Clarke, Einstein Lead ACCC; Changes At CCSG, Cohen Leaves USC For Childhood Foundation

April 17, 1992

Funding Opportunities: Komen Foundation Seeks Reviewers

February 28, 1997

FDA Grants Accelerated Approval To Ferriprox for Iron Overload

October 28, 2011

Biology Societies Endorse Cloning Prohibition Act.

February 1, 2002

In Brief: Nominations Open For Bristol-Myers Award; New Surgical Oncology Chair At South Florida

September 7, 1984

Taxol Patents Reveal Bristol Strategy to Safeguard Market Against Competitors

July 4, 1997